EMD-24126
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
EMD-24126
Single-particle4.0 Å
Deposition: 28/05/2021Map released: 07/07/2021
Last modified: 30/10/2024
Sample Organism:
Severe acute respiratory syndrome coronavirus 2
Sample: one RBD-up-3 of pre-fusion SARS-CoV-2 B.1.1.7 spike variant glycoprotein
Fitted models: 7n1x
Deposition Authors: Zhang J
,
Cai YF
Sample: one RBD-up-3 of pre-fusion SARS-CoV-2 B.1.1.7 spike variant glycoprotein
Fitted models: 7n1x
Deposition Authors: Zhang J
,
Cai YF
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants.
Cai Y ,
Zhang J ,
Xiao T ,
Lavine CL ,
Rawson S ,
Peng H ,
Zhu H ,
Anand K,
Tong P ,
Gautam A ,
Lu S,
Sterling SM ,
Walsh Jr RM ,
Rits-Volloch S,
Lu J,
Wesemann DR ,
Yang W ,
Seaman MS ,
Chen B
(2021) Science , 373 , 642 - 648
,
Zhang J ,
Xiao T ,
Lavine CL ,
Rawson S ,
Peng H ,
Zhu H ,
Anand K,
Tong P ,
Gautam A ,
Lu S,
Sterling SM ,
Walsh Jr RM ,
Rits-Volloch S,
Lu J,
Wesemann DR ,
Yang W ,
Seaman MS ,
Chen B
(2021) Science , 373 , 642 - 648
Grant Support:
- National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID): AI147884 (United States)
- National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID): AI141002 (United States)
- National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID): AI127193 (United States)